299 related articles for article (PubMed ID: 24067260)
1. Plasma cannabinoid concentrations during dronabinol pharmacotherapy for cannabis dependence.
Milman G; Bergamaschi MM; Lee D; Mendu DR; Barnes AJ; Vandrey R; Huestis MA
Ther Drug Monit; 2014 Apr; 36(2):218-24. PubMed ID: 24067260
[TBL] [Abstract][Full Text] [Related]
2. Delta(9)-tetrahydrocannabinol, 11-hydroxy-delta(9)-tetrahydrocannabinol and 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids.
Goodwin RS; Gustafson RA; Barnes A; Nebro W; Moolchan ET; Huestis MA
Ther Drug Monit; 2006 Aug; 28(4):545-51. PubMed ID: 16885723
[TBL] [Abstract][Full Text] [Related]
3. Oral fluid cannabinoids in chronic cannabis smokers during oral δ9-tetrahydrocannabinol therapy and smoked cannabis challenge.
Lee D; Vandrey R; Mendu DR; Anizan S; Milman G; Murray JA; Barnes AJ; Huestis MA
Clin Chem; 2013 Dec; 59(12):1770-9. PubMed ID: 23938457
[TBL] [Abstract][Full Text] [Related]
4. Predictive model accuracy in estimating last Δ9-tetrahydrocannabinol (THC) intake from plasma and whole blood cannabinoid concentrations in chronic, daily cannabis smokers administered subchronic oral THC.
Karschner EL; Schwope DM; Schwilke EW; Goodwin RS; Kelly DL; Gorelick DA; Huestis MA
Drug Alcohol Depend; 2012 Oct; 125(3):313-9. PubMed ID: 22464363
[TBL] [Abstract][Full Text] [Related]
5. Oral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration.
Lee D; Vandrey R; Milman G; Bergamaschi M; Mendu DR; Murray JA; Barnes AJ; Huestis MA
Anal Bioanal Chem; 2013 Sep; 405(23):7269-79. PubMed ID: 23831756
[TBL] [Abstract][Full Text] [Related]
6. Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration.
Schwope DM; Karschner EL; Gorelick DA; Huestis MA
Clin Chem; 2011 Oct; 57(10):1406-14. PubMed ID: 21836075
[TBL] [Abstract][Full Text] [Related]
7. Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?
Lee D; Karschner EL; Milman G; Barnes AJ; Goodwin RS; Huestis MA
Drug Alcohol Depend; 2013 Jun; 130(1-3):68-76. PubMed ID: 23146820
[TBL] [Abstract][Full Text] [Related]
8. Plasma Cannabinoid Pharmacokinetics After Controlled Smoking and Ad libitum Cannabis Smoking in Chronic Frequent Users.
Lee D; Bergamaschi MM; Milman G; Barnes AJ; Queiroz RH; Vandrey R; Huestis MA
J Anal Toxicol; 2015 Oct; 39(8):580-7. PubMed ID: 26378131
[TBL] [Abstract][Full Text] [Related]
9. Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance.
Karschner EL; Swortwood MJ; Hirvonen J; Goodwin RS; Bosker WM; Ramaekers JG; Huestis MA
Drug Test Anal; 2016 Jul; 8(7):682-9. PubMed ID: 26097154
[TBL] [Abstract][Full Text] [Related]
10. Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana.
Huestis MA; Henningfield JE; Cone EJ
J Anal Toxicol; 1992; 16(5):276-82. PubMed ID: 1338215
[TBL] [Abstract][Full Text] [Related]
11. Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC.
Schwilke EW; Schwope DM; Karschner EL; Lowe RH; Darwin WD; Kelly DL; Goodwin RS; Gorelick DA; Huestis MA
Clin Chem; 2009 Dec; 55(12):2180-9. PubMed ID: 19833841
[TBL] [Abstract][Full Text] [Related]
12. The effect of high-dose dronabinol (oral THC) maintenance on cannabis self-administration.
Schlienz NJ; Lee DC; Stitzer ML; Vandrey R
Drug Alcohol Depend; 2018 Jun; 187():254-260. PubMed ID: 29689485
[TBL] [Abstract][Full Text] [Related]
13. Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral Δ(9)-tetrahydrocannabinol administration.
Milman G; Schwope DM; Schwilke EW; Darwin WD; Kelly DL; Goodwin RS; Gorelick DA; Huestis MA
Clin Chem; 2011 Nov; 57(11):1597-606. PubMed ID: 21875944
[TBL] [Abstract][Full Text] [Related]
14. Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis.
Desrosiers NA; Himes SK; Scheidweiler KB; Concheiro-Guisan M; Gorelick DA; Huestis MA
Clin Chem; 2014 Apr; 60(4):631-43. PubMed ID: 24563491
[TBL] [Abstract][Full Text] [Related]
15. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.
Lee D; Milman G; Barnes AJ; Goodwin RS; Hirvonen J; Huestis MA
Clin Chem; 2011 Aug; 57(8):1127-36. PubMed ID: 21677094
[TBL] [Abstract][Full Text] [Related]
16. In vitro stability of free and glucuronidated cannabinoids in blood and plasma following controlled smoked cannabis.
Scheidweiler KB; Schwope DM; Karschner EL; Desrosiers NA; Gorelick DA; Huestis MA
Clin Chem; 2013 Jul; 59(7):1108-17. PubMed ID: 23519966
[TBL] [Abstract][Full Text] [Related]
17. Acute Pharmacokinetic Profile of Smoked and Vaporized Cannabis in Human Blood and Oral Fluid.
Spindle TR; Cone EJ; Schlienz NJ; Mitchell JM; Bigelow GE; Flegel R; Hayes E; Vandrey R
J Anal Toxicol; 2019 May; 43(4):233-258. PubMed ID: 30615181
[TBL] [Abstract][Full Text] [Related]
18. Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake.
Newmeyer MN; Swortwood MJ; Barnes AJ; Abulseoud OA; Scheidweiler KB; Huestis MA
Clin Chem; 2016 Dec; 62(12):1579-1592. PubMed ID: 27899456
[TBL] [Abstract][Full Text] [Related]
19. Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers.
Karschner EL; Schwilke EW; Lowe RH; Darwin WD; Herning RI; Cadet JL; Huestis MA
J Anal Toxicol; 2009 Oct; 33(8):469-77. PubMed ID: 19874654
[TBL] [Abstract][Full Text] [Related]
20. Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking.
Lee D; Vandrey R; Mendu DR; Murray JA; Barnes AJ; Huestis MA
Drug Test Anal; 2015 Jun; 7(6):494-501. PubMed ID: 25220020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]